Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
ScinoPharm Taiwan Ltd
TWSE:1789
ScinoPharm Taiwan Ltd
TWSE:1789
Price:
19.65
TWD
-1.75%
Market Cap:
NT$15.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
Price Forecast
Based on 3 analysts
Based on 3 analysts
+12% Upside
from
NT$19.65
today
ScinoPharm Taiwan Ltd (1789)’s 12-month stock price forecast through November 2027 has a consensus target of NT$21.93, implying 12% upside. The forecast is based on price targets from 3 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
ScinoPharm Taiwan Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ScinoPharm Taiwan Ltd's stock price target?
Price Target
21.93
TWD
21.93
TWD
According to Wall Street analysts, the average 1-year price target for ScinoPharm Taiwan Ltd is 21.93 TWD with a low forecast of 21.72 TWD and a high forecast of 22.58 TWD.
What is the Revenue forecast for ScinoPharm Taiwan Ltd?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 2 years is 10%.
What is the Gross Profit forecast for ScinoPharm Taiwan Ltd?
Projected CAGR
15%
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -6%. The projected CAGR for the next 2 years is 15%.
What is the Operating Income forecast for ScinoPharm Taiwan Ltd?
Projected CAGR
96%
96%
Over the last 13 years, the compound annual growth rate for Operating Income has been -17%. The projected CAGR for the next 2 years is 96%.
What is the Pre-Tax Income forecast for ScinoPharm Taiwan Ltd?
Projected CAGR
78%
78%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 2 years is 78%.
What is the Net Income forecast for ScinoPharm Taiwan Ltd?
Projected CAGR
66%
66%
Over the last 13 years, the compound annual growth rate for Net Income has been -15%. The projected CAGR for the next 2 years is 66%.
